Overusing reliever inhaler (HP277)

Overusing reliever inhaler (HP277)

Purpose:

This protocol will:
  1. Ensures poorly controlled asthmatics are flagged to users so that they can be reviewed


What does it actually do?

The protocol performs the following functions:
  1. Checks when loading the record if the patient is asthmatic
  2. Assesses whether an asthmatic patient has had 6 or more issues of their short acting beta-agonist in the last 12 months
  3. If they have had at least 6 issues, flag this to the user for attention


What does it look like?





How to get it

This protocol is an optional handy protocol, if you'd like this activating in your site please submit a ticket to request this.


    • Related Articles

    • Inhaler Management | Inhaler Technique

      ? Inhaler Technique Correct inhaler technique is essential to asthma control. This shared template component appears across multiple PCIT templates and supports structured observation, coaching, and documentation. ? When Will I See This? During ...
    • Inhaler Management | Adherence to Inhaled Therapy

      ? Adherence to Inhaled Therapy Adherence to asthma medication is critical to achieving good symptom control and preventing exacerbations. This shared component supports structured conversations to identify non-adherence and plan support. ? When ...
    • Diagnosis | Inhaler Review Alert – Dormant or Resolved Coding

      ? Inhaler Review Alert – Dormant or Resolved Coding This shared component appears when a patient with an asthma diagnosis has not been issued an inhaler in the past 12 months. It prompts clinicians to reassess whether the diagnosis is still active ...
    • Asthma Protocols

      We have built a suite of Protocol resources to support you with Asthma within the EMIS Clinical System. Please follow the links below for the supporting information: QOF Related Asthma review not fully completed (HP213) New asthmatic needs ...
    • History and Control | SABA Overuse Alert (6+ in 6 Months)

      ? SABA Overuse Alert (6+ in 6 Months) This shared component flags when a patient has been issued six or more Short-Acting Beta-Agonist (SABA) inhalers (e.g. salbutamol) in the past 6 months. It serves as a key marker of poor asthma control and risk ...